Home Tags Posts tagged with "Angus Xie"

Tag: Angus Xie

Multinational antitrust reviews
Practitioners' perspectives

Multinational antitrust reviews in pharma M&A

By Angus Xi, Han Kun Law Offices

In recent years, M&A in the global biopharmaceutical sector has remained highly active

0
Sino Biopharmaceutical's LaNova acquisition
Deal Highlights

Han Kun, Zhong Lun act on Sino Biopharm’s USD950m LaNova buy

Han Kun and Zhong Lun advised on Sino Biopharm’s USD950m acquisition of cancer drugmaker LaNova Medicines

0
CBLJ-rising-star-2024-report
Market watch

The A-List 2023-24: Rising Stars

When helping clients navigate a complex legal landscape, young elite lawyers have brought fresh ideas and innovative approaches to the table

0
Vertical restraint: the 'grey rhino' in anti-monopoly compliance
Practitioners' perspectives

Vertical restraint: the ‘grey rhino’ in anti-monopoly compliance

By Angus Xie and Guo Xiao, Han Kun Law Offices
0
Market pulse

Han Kun hires boost compliance, antitrust

0

LATEST ON LAW.ASIA

MOST READ ON LAW.ASIA

Correspondents

India Healthcare Investmentvideo

Healthcare investment in India: The PE playbook

By Ayush Jain, Bharucha & Partners
Philippine Citizenship By Marriage

Bride and prejudice: Gendered paths to Philippine citizenship

By Jewel M Culala, ACCRALAW
AI investments in Indiavideo

Rethinking due diligence for Indian AI deals

By Vandana Pai and Shreya Sreesankar, Bharucha & Partners
NCLAT shields enforcement actions

PMLA free pass dilutes insolvency moratorium

By Ambar Bhushan and Divyam Sharma, Bharucha & Partners
Follow Law.asia
Law firms Awards Events Legal jobs • Post a job
About us Archive Subscribe Contact us
Please send any press releases, deal announcements, details of new hires, newsletters and any other news items to: news@law.asia
© Copyright 2026 Law.asia Limited. All rights reserved.

Follow us on LinkedIn

Follow now
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.